Mutations in Both KRAS and BRAF May Contribute to the Methylator Phenotype in Colon Cancer

Gastroenterology

Volumn 134, Issue 7, 2008, Pages

  Nagasaka, Takeshi ^a   Koi, Minoru ^a   Kloor, Matthias ^b   Gebert, Johannes ^b   Vilkin, Alex ^a   Nishida, Naoshi ^a   Shin, Sung Kwan ^a   Sasamoto, Hiromi ^c   Tanaka, Noriaki ^c   Matsubara, Nagahide ^c   Boland, C Richard ^a   Goel, Ajay ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; K RAS PROTEIN;

ADULT; ARTICLE; COLON CANCER; CONTROLLED STUDY; CPG ISLAND; FAMILIAL CANCER; FEMALE; GENE LOCUS; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; MICROSATELLITE INSTABILITY; ONCOGENE; ONCOGENE BRAF; ONCOGENE K RAS; PHENOTYPE; PRIORITY JOURNAL;

EID: 44849132638     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.02.094     Document Type: Article

References (40)

1. Herman J.G., and Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349 (2003) 2042-2054
2. Toyota M., Ahuja N., Ohe-Toyota M., et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96 (1999) 8681-8686
3. Issa J.P., Shen L., and Toyota M. CIMP, at last. Gastroenterology 129 (2005) 1121-1124
4. Goel A., Nagasaka T., Arnold C.N., et al. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 132 (2007) 127-138
5. Eads C.A., Lord R.V., Wickramasinghe K., et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 61 (2001) 3410-3418
6. Esteller M., Tortola S., Toyota M., et al. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 60 (2000) 129-133
7. Yamashita K., Dai T., Dai Y., et al. Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell 4 (2003) 121-131
8. Samowitz W.S., Albertsen H., Herrick J., et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129 (2005) 837-845
9. Ogino S., Kawasaki T., Kirkner G.J., et al. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn 9 (2007) 305-314
10. Davies H., Bignell G.R., Cox C., et al. Mutations of the BRAF gene in human cancer. Nature 417 (2002) 949-954
11. Weisenberger D.J., Siegmund K.D., Campan M., et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38 (2006) 787-793
12. Toyota M., Ohe-Toyota M., Ahuja N., et al. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc Natl Acad Sci U S A 97 (2000) 710-715
13. Toyota M., and Issa J.P. CpG island methylator phenotypes in aging and cancer. Semin Cancer Biol 9 (1999) 349-357
14. Samowitz W.S., Albertsen H., Sweeney C., et al. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst 98 (2006) 1731-1738
15. Shen L., Kondo Y., Hamilton S.R., et al. P14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53. Gastroenterology 124 (2003) 626-633
16. Slattery M.L., Curtin K., Sweeney C., et al. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer 120 (2007) 656-663
17. Nagasaka T., Sasamoto H., Notohara K., et al. Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol 22 (2004) 4584-4594
18. Iacopetta B., Grieu F., Li W., et al. APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer. Int J Cancer 119 (2006) 2272-2278
19. Kim J.S., Lee C., Foxworth A., et al. B-Raf is dispensable for K-Ras-mediated oncogenesis in human cancer cells. Cancer Res 64 (2004) 1932-1937
20. Ordway J.M., Williams K., and Curran T. Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1. Oncogene 23 (2004) 3737-3748
21. Xiong Z., and Laird P.W. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 25 (1997) 2532-2534
22. Suzuki H., Watkins D.N., Jair K.W., et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36 (2004) 417-422
23. Hesson L.B., Wilson R., Morton D., et al. CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations. Oncogene 24 (2005) 3987-3994
24. Takahashi T., Shigematsu H., Shivapurkar N., et al. Aberrant promoter methylation of multiple genes during multistep pathogenesis of colorectal cancers. Int J Cancer 118 (2006) 924-931
25. Akino K., Toyota M., Suzuki H., et al. The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. Gastroenterology 129 (2005) 156-169
26. Esteller M., Sparks A., Toyota M., et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 60 (2000) 4366-4371
27. Young J., Biden K.G., Simms L.A., et al. HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proc Natl Acad Sci U S A 98 (2001) 265-270
28. Miyamoto K., Asada K., Fukutomi T., et al. Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers. Oncogene 22 (2003) 274-280
29. Nagasaka T., Sharp G.B., Notohara K., et al. Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases. Clin Cancer Res 9 (2003) 5306-5312
30. Boland C.R., Thibodeau S.N., Hamilton S.R., et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58 (1998) 5248-5257
31. Kambara T., Matsubara N., Nakagawa H., et al. High frequency of low-level microsatellite instability in early colorectal cancer. Cancer Res 61 (2001) 7743-7746
32. Kambara T., Simms L.A., Whitehall V.L., et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53 (2004) 1137-1144
33. Ogino S., Kawasaki T., Kirkner G.J., et al. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn 8 (2006) 582-588
34. An C., Choi I.S., Yao J.C., et al. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin Cancer Res 11 (2005) 656-663
35. Rashid A., Shen L., Morris J.S., et al. CpG island methylation in colorectal adenomas. Am J Pathol 159 (2001) 1129-1135
36. Shen L., Toyota M., Kondo Y., et al. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A 104 (2007) 18654-18659
37. Gazin C., Wajapeyee N., Gobeil S., et al. An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 449 (2007) 1073-1077
38. Jass J.R., Whitehall V.L., Young J., et al. Emerging concepts in colorectal neoplasia. Gastroenterology 123 (2002) 862-876
39. Rosenberg D.W., Yang S., Pleau D.C., et al. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. Cancer Res 67 (2007) 3551-3554
40. Yamamoto H., Min Y., Itoh F., et al. Differential involvement of the hypermethylator phenotype in hereditary and sporadic colorectal cancers with high-frequency microsatellite instability. Genes Chromosomes Cancer 33 (2002) 322-325